[1] 张玄娥,曲伸.高尿酸血症的现代进化与多重性作用——从炎症角度审视高尿酸血症[J].中华内分泌代谢杂志,2019,35(8):718-722.DOI:10.3760/cma.j.issn.1000-6699. 2019.08.013.
[2] 李静.高尿酸血症的流行病学研究[J].中国心血管杂志,2016,21(2):83-86.DOI:10.3969/j.issn.1007-5410. 2016.02.001.
[3] Kamatani N.Diagnosis and treatment of hyperuricemia and gout[J].Nihon Naika Gakkai Zasshi,2007,96(3):510-514.Japanese.DOI:10.2169/naika.96.510.
[4] Yu KH,Chen DY,Chen JH,et al.Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan[J].Int J Rheum Dis,2018,21(4):772-787.DOI:10.1111/1756-185X.13266.
[5] 马金魁,张宏斌.高尿酸血症及治疗药物的研究进展[J].广东医学,2018,39(z1):262-267.DOI:10.3969/j.issn. 1001-9448.2018.z1.093.
[6] 高泽燕,吕珂.高尿酸血症诊治中超声应用价值及进展[J].中国医学科学院学报,2017,39(2):280-284.DOI:10.3881/j.issn.1000-503X.2017.02.019.
[7] Evans PL,Prior JA,Belcher J,et al.Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies[J].Arthritis Res Ther,2018,20(1):136.DOI:10.1186/s13075-018-1612-1.
[8] Thottam GE,Krasnokutsky S,Pillinger MH.Gout and metabolic syndrome: a tangled web[J].Curr Rheumatol Rep,2017,19(10):60.DOI:10.1007/s11926-017-0688-y.
[9] 周丹萍,王红梦,章丽芳,等.追踪护理模式对食管癌患者放化疗期间的影响[J].浙江创伤外科,2023,28(4):797-799.DOI:10.3969/j.issn.1009-7147.2023.04.058.
[10] 严婷婷. 追踪护理模式在血液透析病人营养状态全程管理中的应用效果分析[J/CD].实用临床护理学电子杂志,2019,4(16):178-179.
[11] 徐妙,贠晓丹,薛瑾丹. 追踪护理模式对食管癌放疗患者营养状况的影响分析[J/CD].临床医药文献电子杂志,2019,6(42):97-98.
[12] 李金平.追踪护理模式联合个体化系统营养干预对食管癌放疗患者营养状况的影响[J].当代护士(上旬刊),2019,26(11):69-71.DOI:10.3969/j.issn.1006-6411. 2019.11.030.
[13] 中华医学会风湿病学分会.2016中国痛风诊疗指南[J].中华内科杂志,2016,55(11):892-899.DOI:10.3760/cma.j.issn.0578-1426.2016.11.019.
[14] 中国医师协会肾脏内科医师分会.中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J].中华医学杂志,2017,97(25):1927-1936.DOI:10.3760/cma.j.issn.0376-2491. 2017.25.003.
[15] 朱亮,吴华香.«中国高尿酸血症相关疾病诊疗多学科专家共识»解读[J].中华医学信息导报,2017,32(11):22.DOI:10.3969/cma.j.issn.1000-8039.2017.11.022.
[16] 高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志,2017,56(3):235-248.DOI:10.3760/cma.j.issn.0578-1426. 2017.03.021.
[17] 张洁筠.体检人群血尿酸水平与代谢综合征及其组分的关系研究[J].中国医学创新,2019,16(12):132-135.DOI:10.3969/j.issn.1674-4985.2019.12.034.
[18] Petrie JL,Patman GL,Sinha I,et al.The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis[J].American Journal of Physiology,2013,305(5 Pt.1):E1255-E1265.DOI:10.1152/ajpendo.00214.2013.
[19] Escudero C,Bertoglia P,Muñoz F,et al.Uric acid and purine plasma levels as plausible markers for placental dysfunction in pre-eclampsia[J].Rev Med Chil,2013,141(7):895-902.Spanish.DOI:10.4067/S0034- 98872013000700009.
[20] 王凤娇,李明,张秀娟,等.血尿酸与代谢性风险[J].中国微生态学杂志,2016,28(5):618-620.DOI:10.13381/j.cnki.cjm.201605033.
[21] Smolen LJ,Gahn JC,Mitri G,et al.The budget impact of increased use of febuxostat in the management of gout: a us health plan managed care pharmacy and medical costs perspective[J].Clin Ther,2016,38(7):1710-1725.DOI:10.1016/j.clinthera.2016.05.007.
[22] Becker MA,Ruoff GE.What do I need to know about gout?[J].J Fam Pract,2010,59(6 Suppl):S1-8.
[23] 姚越峰,陈美爱,李宝英.肌骨彩超检测无症状高尿酸血症患者关节尿酸晶体沉积对痛风性肾病预测作用的研究[J].国际医药卫生导报,2019,25(16):2658-2659.DOI:10.3760/cma.j.issn.1007-1245.2019.16.010.
[24] 袁建丽,彭梦仙,孙敏,等.痛风发病机理及其药物治疗现状和展望[J].中国药事,2014,28(1):86-90.
[25] 谢昭宁.邕宁区1992名体检人群血尿酸分析[J].国际检验医学杂志,2013,34(2):169-170.DOI:10.3969/j.issn. 1673-4130.2013.02.019.
[26] Ramirez-Sandoval JC,Madero M.Treatment of hyperuricemia in chronic kidney disease[J].Contrib Nephrol,2018,192:135-146.DOI:10.1159/000484288.
|